CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019 Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological Technologies Complete Revascularization with Multivessel PCI for Myocardial Infarction

Clinical Trial2021 Apr 10;28(2):227-234.

JOURNAL:Eur J Prev Cardiol. Article Link

No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study

L Miao, GX Deng, RX Yin et al. Keywords: plasma homocysteine levels; CHD; AMI; mendelian randomization study

Full Text PDF